Department of Pharmaceutical Technology, Jadavpur University, Kolkata, West Bengal, India.
Int J Nanomedicine. 2011;6:619-29. doi: 10.2147/IJN.S14621. Epub 2011 Mar 30.
Development of a novel delivery system has been attempted to deliver viable probiotic cells into the gut for a prolonged period of time while maintaining high numbers of viable cells within the formulation throughout the shelf-life of the product and during the gastrointestinal transit. Core mucoadhesive microspheres of Bacillus coagulans were developed employing several grades of hypromellose, a mucoadhesive polymer, following coacervation and phase separation technique and were subsequently enteric-coated with hypromellose phthalate. Microspheres were evaluated for percent yield; entrapment efficiency; in vitro swelling; surface morphology; particle size, size distribution, and zeta potential; flow property, mucoadhesion property by the ex vivo mucoadhesive strength test and the in vitro wash off test; in vitro release profile and release kinetic; in vivo probiotic activity; and stability. The values for the kinetic constant and regression coefficient of model-dependent approaches and the difference factor (f(1)), the similarity factor (f(2)), and the Rescigno index (ξ(1) and ξ(2)) of model independent approaches were determined for comparing in vitro dissolution profiles. Freeze dried B. coagulans cells were successfully formulated as enteric-coated mucoadhesive microspheres with satisfactory physical structure and yield. The viability of B. coagulans was maintained in the simulated gastric conditions and during processing; in simulated intestinal conditions exhibiting mucoadhesion, and controlling and extending the viable cell release following zero-order; and was satisfactorily stable at room temperature. Test results depict statistically significant effects of the hypromellose grade and their concentration on the performance and release profile of formulations.
已尝试开发一种新型递送系统,以便将活菌益生菌细胞递送至肠道中,从而在产品的保质期内和胃肠道转运过程中长时间维持制剂内的高活菌数量。采用几种等级的羟丙甲纤维素(一种粘膜粘附聚合物),通过共凝聚和相分离技术开发凝结芽孢杆菌的核心粘膜粘附微球,随后用羟丙甲纤维素邻苯二甲酸酯进行肠溶包衣。对微球的收率、包封效率、体外膨胀、表面形态、粒径、粒径分布和 Zeta 电位、流动特性、体外粘膜粘附强度试验和体外冲洗试验的粘膜粘附特性、体外释放曲线和释放动力学、体内益生菌活性和稳定性进行评估。采用模型依赖和模型独立方法,确定了动力学常数和回归系数值、差异因子(f(1))、相似因子(f(2))和 Rescigno 指数(ξ(1)和 ξ(2)),以比较体外溶解曲线。成功地将冷冻干燥的凝结芽孢杆菌细胞制成肠溶粘膜粘附微球,具有令人满意的物理结构和收率。在模拟胃条件下和加工过程中保持凝结芽孢杆菌的活力;在模拟肠条件下表现出粘膜粘附性,并控制和延长零级后的活菌释放;在室温下稳定性能良好。测试结果表明,羟丙甲纤维素等级及其浓度对制剂的性能和释放曲线有统计学意义的影响。